Nestle

Last updated January 31, 2026

125

Innovation Areas

3,230

Inventors

Collaborations

Ank1 and nkx6.3 genetic modulation: NestleRecent Research Landscape

Uncontrolled ALK signaling drives oncogenic transformation and therapeutic resistance. These innovations utilize small-molecule or biologic modulation of the kinase domain to arrest tumor progression.

What technical problems is Nestle addressing in Ank1 and nkx6.3 genetic modulation?

Neurological metabolic energy deficiency

(5)evidences

Low metabolic conversion rates of dietary fats into therapeutic ketones. Increasing ketone availability prior to glucose spikes improves metabolic efficiency and systemic health outcomes.

Metabolic homeostasis failure

(5)evidences

Inadequate systemic physiological balance leads to suboptimal animal health and disease susceptibility. Enhancing genetic modulation of metabolic pathways prevents chronic physiological decline.